Genetics of primary ovarian insufficiency: a review

Journal of Assisted Reproduction and Genetics

Volumn 31, Issue 12, 2014, Pages 1573-1585

  Fortuño, Cristina ^a   Labarta, Elena ^a  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

Author keywords

Candidate genes; Genetic factors; Ovarian reserve; Primary ovarian insufficiency; Sex chromosome abnormalities

Indexed keywords

ANEUPLOIDY; ARTICLE; AUTOSOMAL INHERITANCE; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC VARIABILITY; HEREDITY; HUMAN; MEDICAL GENETICS; NONHUMAN; PREMATURE OVARIAN FAILURE; SEX CHROMOSOME ABERRATION; X CHROMOSOME; X CHROMOSOME ABERRATION; AUTOIMMUNE DISEASE; FEMALE INFERTILITY; GENETICS; PATHOLOGY; PREGNANCY; PRIMARY OVARIAN INSUFFICIENCY; VIROLOGY;

AUTOIMMUNE DISEASES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PRIMARY OVARIAN INSUFFICIENCY; SEX CHROMOSOME ABERRATIONS;

EID: 84914099173     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-014-0342-9     Document Type: Article

References (93)

1. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360:606–14.
2. Visser JA, Schipper I, Laven JS, Themmen AP. Anti-Mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8:331–41.
3. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010;376:911–21.
4. Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008;68:499–509.
5. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–6.
6. Aubuchon M, Santoro N. Lessons learned from the WHI: HRT requires a cautious and individualized approach. Geriatrics. 2004;59:22–6.
7. van Kasteren YM, Hundscheid RD, Smits AP, Cremers FP, van Zonneveld P, Braat DD. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod. 1999;14:2455–9.
8. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;1:9.
9. Cordts EB, Christofolini DM, Dos Santos AA, Bianco B, Barbosa CP. Genetic aspects of premature ovarian failure: a literature review. Arch Gynecol Obstet. 2011;283:635–43.
10. Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann N Y Acad Sci. 2008;1135:146–54.
11. Chakhtoura Z, Touraine P. Fertility on women with Turner syndrome. Presse Med. 2013;42:1508–12.
12. Fenichel P, Brucker-Davis F. Environmental endocrine disruptors and breast cancer: new risk factors? Gynecol Obstet Fertil. 2008;36:969–77.
13. Hagman A, Kallen K, Bryman I, Landin-Wilhelmsen K, Barrenas ML, Wennerholm UB. Morbidity and mortality after childbirth in women with Turner karyotype. Hum Reprod. 2013;28:1961–73.
14. Fenichel P, Letur H. Procreation in Turner’s syndrome: which recommendations before, during and after pregnancy? Gynecol Obstet Fertil. 2008;36:891–7.
15. Otter M, Schrander-Stumpel CT, Curfs LM. Triple X syndrome: a review of the literature. Eur J Hum Genet. 2010;18:265–71.
16. Goswami R, Goswami D, Kabra M, Gupta N, Dubey S, Dadhwal V. Prevalence of the triple X syndrome in phenotypically normal women with premature ovarian failure and its association with autoimmune thyroid disorders. Fertil Steril. 2003;80:1052–4.
17. Collen RJ, Falk RE, Lippe BM, Kaplan SA. A 48, XXXX female with absence of ovaries. Am J Med Genet. 1980;6:275–8.
18. Wood A, Kleis L, Toriello H, Cemeroglu AP. Mosaic pentasomy X/tetrasomy X syndrome and premature ovarian failure. Indian Pediatr. 2011;48:402–4.
19. Simpson JL. Gonadal dysgenesis and abnormalities of the human sex chromosomes: current status of phenotypic-karyotypic correlations. Birth Defects Orig Artic Ser. 1975;11:23–59.
20. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005;11:391–410.
21. Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol. 2010;45:257–79.
22. Bertini V, Ghirri P, Bicocchi MP, Simi P, Valetto A. Molecular cytogenetic definition of a translocation t(X;15) associated with premature ovarian failure. Fertil Steril. 2010;94:1097.e5–e8.
23. Bashamboo A, Ravel C, Brauner R, McElreavey K. NR5A1 and ovarian failure. Med Sci (Paris). 2009;25:809–13.
24. Paliwal P, Sharma A, Birla S, Kriplani A, Khadgawat R, Sharma A. Identification of novel SRY mutations and SF1 (NR5A1) changes in patients with pure gonadal dysgenesis and 46, XY karyotype. Mol Hum Reprod. 2011;17:372–8.
25. Polakova M, Alexander D, Sulc J, Zetova L, Vlk R, Krepelova A, et al. Pregnancy and delivery in a patient with pure 46, XY karyotype. Summary of actual knowledge about XY women. Ceska Gynekol. 2013;78:443–7.
26. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87:456–65.
27. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:127–30.
28. Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet. 2004;74:1051–6.
29. Utari A, Adams E, Berry-Kravis E, Chavez A, Scaggs F, Ngotran L, et al. Aging in fragile X syndrome. J Neurodev Disord. 2010;2:70–6.
30. Yang JC, Simon C, Schneider A, Seritan AL, Hamilton L, Hagerman PJ, et al. Abnormal semantic processing in females with fragile X-associated tremor/ataxia syndrome. Genes Brain Behav. 2014;13:152–62.
31. Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, et al. Phenotypes of hypofrontality in older female fragile X premutation carriers. Ann Neurol. 2013;74:275–83.
32. Nayot D, Chung JT, Son WY, Ao A, Hughes M, Dahan MH. Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve. J Assist Reprod Genet. 2013;30:1439–44.
33. Kallinen J, Korhonen K, Kortelainen S, Heinonen S, Ryynanen M. Pregnancy outcome in carriers of fragile X. BJOG. 2000;107:969–72.
34. Platteau P, Sermon K, Seneca S, Van Steirteghem A, Devroey P, Liebaers I. Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible. Hum Reprod. 2002;17:2807–12.
35. Murray A, Webb J, Dennis N, Conway G, Morton N. Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J Med Genet. 1999;36:767–70.
36. Dixit H, Rao L, Padmalatha V, Raseswari T, Kapu AK, Panda B, et al. Genes governing premature ovarian failure. Reprod Biomed Online. 2010;20:724–40.
37. Chatterjee S, Singh R, Kadam S, Maitra A, Thangaraj K, Meherji P, et al. Longer CAG repeat length in the androgen receptor gene is associated with premature ovarian failure. Hum Reprod. 2009;24:3230–5.
38. Fonseca DJ, Garzon E, Lakhal B, Braham R, Ojeda D, Elghezal H, et al. Screening for mutations of the FOXO4 gene in premature ovarian failure patients. Reprod Biomed Online. 2012;24:339–41.
39. Peng C. The TGF-beta superfamily and its roles in the human ovary and placenta. J Obstet Gynaecol Can. 2003;25:834–44.
40. Tachdjian G, Aboura A, Portnoi MF, Pasquier M, Bourcigaux N, Simon T, et al. Cryptic Xp duplication including the SHOX gene in a woman with 46, X, del(X)(q21.31) and premature ovarian failure. Hum Reprod. 2008;23:222–6.
41. Ghadami M, El-Demerdash E, Salama SA, Binhazim AA, Archibong AE, Chen X, et al. Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(−/−) FORKO mice. Mol Hum Reprod. 2010;16:241–50.
42. Grynberg M, Peltoketo H, Christin-Maitre S, Poulain M, Bouchard P, Fanchin R. First birth achieved after in vitro maturation of oocytes from a woman endowed with multiple antral follicles unresponsive to follicle-stimulating hormone. J Clin Endocrinol Metab. 2013;98:4493–8.
43. Arnhold IJ, Latronico AC, Batista MC, Izzo CR, Mendonca BB. Clinical features of women with resistance to luteinizing hormone. Clin Endocrinol (Oxf). 1999;51:701–7.
44. Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod. 2002;8:729–33.
45. Roth LW, Alvero R. Pregnancy in a woman with premature ovarian insufficiency associated with blepharophimosis, ptosis, epicanthus inversus syndrome type I. A case report. J Reprod Med. 2014;59:87–9.
46. Gubbels CS, Land JA, Rubio-Gozalbo ME. Fertility and impact of pregnancies on the mother and child in classic galactosemia. Obstet Gynecol Surv. 2008;63:334–43.
47. Fierabracci A, Bizzarri C, Palma A, Milillo A, Bellacchio E, Cappa M. A novel heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED). Gene. 2012;511:113–7.
48. Bhangoo A, Buyuk E, Oktay K, Ten S. Phenotypic features of 46, XX females with StAR protein mutations. Pediatr Endocrinol Rev. 2007;5:633–41.
49. Pellicer A, Miro F, Sampaio M, Gomez E, Bonilla-Musoles FM. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20-desmolase deficiency. Fertil Steril. 1991;55:970–5.
50. Kim S, Pyun JA, Cha DH, Ko JJ, Kwack K. Epistasis between FSHR and CYP19A1 polymorphisms is associated with premature ovarian failure. Fertil Steril. 2011;95:2585–8.
51. Fogli A, Gauthier-Barichard F, Schiffmann R, Vanderhoof VH, Bakalov VK, Nelson LM, et al. Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure. BMC Womens Health. 2004;4:8.
52. Kosaki K, Sato S, Hasegawa T, Matsuo N, Suzuki T, Ogata T. Premature ovarian failure in a female with proximal symphalangism and Noggin mutation. Fertil Steril. 2004;81:1137–9.
53. Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet. 2004;364:875–82.
54. Cox L, Liu JH. Primary ovarian insufficiency: an update. Int J Womens Health. 2014;6:235–43.
55. Demirhan O, Turkmen S, Schwabe GC, Soyupak S, Akgul E, Tastemir D, et al. A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. J Med Genet. 2005;42:314–7.
56. Simon AM, Goodenough DA, Li E, Paul DL. Female infertility in mice lacking connexin 37. Nature. 1997;385:525–9.
57. Chand AL, Harrison CA, Shelling AN. Inhibin and premature ovarian failure. Hum Reprod Update. 2010;16:39–50.
58. Dixit H, Rao KL, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, et al. Mutational analysis of the betaglycan gene-coding region in susceptibility for ovarian failure. Hum Reprod. 2006;21:2041–6.
59. Bouilly J, Bachelot A, Broutin I, Touraine P, Binart N. Novel NOBOX loss-of-function mutations account for 6.2 % of cases in a large primary ovarian insufficiency cohort. Hum Mutat. 2011;32:1108–13.
60. Zhao H, Chen ZJ, Qin Y, Shi Y, Wang S, Choi Y, et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet. 2008;82:1342–8.
61. Watkins WJ, Umbers AJ, Woad KJ, Harris SE, Winship IM, Gersak K, et al. Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil Steril. 2006;86:1518–21.
62. Qin Y, Vujovic S, Li G, Li J, Dalgleish R, Simpson JL, et al. Ethnic specificity of variants of the ESR1, HK3, BRSK1 genes and the 8q22.3 locus: No association with premature ovarian failure (POF) in Serbian women. Maturitas. 2014;77:64–7.
63. Liu L, Tan R, Cui Y, Liu J, Wu J. Estrogen receptor alpha gene (ESR1) polymorphisms associated with idiopathic premature ovarian failure in Chinese women. Gynecol Endocrinol. 2013;29:182–5.
64. Gao F, Zhang J, Wang X, Yang J, Chen D, Huff V, et al. Wt1 functions in ovarian follicle development by regulating granulosa cell differentiation. Hum Mol Genet. 2014;23:333–41.
65. Shimizu Y, Kimura F, Takebayashi K, Fujiwara M, Takakura K, Takahashi K. Mutational analysis of the PTEN gene in women with premature ovarian failure. Acta Obstet Gynecol Scand. 2009;88:824–5.
66. Ojeda D, Lakhal B, Fonseca DJ, Braham R, Landolsi H, Mateus HE, et al. Sequence analysis of the CDKN1B gene in patients with premature ovarian failure reveals a novel mutation potentially related to the phenotype. Fertil Steril. 2011;95:2658. 60.e1.
67. Fonseca DJ, Ojeda D, Lakhal B, Braham R, Eggers S, Turbitt E, et al. CITED2 mutations potentially cause idiopathic premature ovarian failure. Transl Res. 2012;160:384–8.
68. Lakhal B, Ben-Hadj-Khalifa S, Bouali N, Braham R, Hatem E, Saad A. Mutational screening of SF1 and WNT4 in Tunisian women with premature ovarian failure. Gene. 2012;509:298–301.
69. Chen B, Suo P, Wang B, Wang J, Yang L, Zhou S, et al. Mutation analysis of the WNT4 gene in Han Chinese women with premature ovarian failure. Reprod Biol Endocrinol. 2011;9:75. 7827-9-75.
70. Mandon-Pepin B, Touraine P, Kuttenn F, Derbois C, Rouxel A, Matsuda F, et al. Genetic investigation of four meiotic genes in women with premature ovarian failure. Eur J Endocrinol. 2008;158:107–15.
71. Kim S, Pyun JA, Kang H, Kim J, Cha DH, Kwack K. Epistasis between CYP19A1 and ESR1 polymorphisms is associated with premature ovarian failure. Fertil Steril. 2011;95:353–6.
72. Hens L, Devroey P, Van Waesberghe L, Bonduelle M, Van Steirteghem AC, Liebaers I. Chromosome studies and fertility treatment in women with ovarian failure. Clin Genet. 1989;36:81–91.
73. Kawano Y, Narahara H, Matsui N, Miyakawa I. Premature ovarian failure associated with a Robertsonian translocation. Acta Obstet Gynecol Scand. 1998;77:467–9.
74. Oldenburg RA, van Dooren MF, de Graaf B, Simons E, Govaerts L, Swagemakers S, et al. A genome-wide linkage scan in a Dutch family identifies a premature ovarian failure susceptibility locus. Hum Reprod. 2008;23:2835–41.
75. Kasippillai T, MacArthur DG, Kirby A, Thomas B, Lambalk CB, Daly MJ, et al. Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency. J Clin Endocrinol Metab. 2013;98:E1534–9.
76. Caburet S, Zavadakova P, Ben-Neriah Z, Bouhali K, Dipietromaria A, Charon C, et al. Genome-wide linkage in a highly consanguineous pedigree reveals two novel loci on chromosome 7 for non-syndromic familial Premature Ovarian Failure. PLoS One. 2012;7:e33412.
77. Caburet S, Arboleda VA, Llano E, Overbeek PA, Barbero JL, Oka K, et al. Mutant cohesin in premature ovarian failure. N Engl J Med. 2014;370:943–9.
78. Yang X, Zhou Y, Peng S, Wu L, Lin HY, Wang S, et al. Differentially expressed plasma microRNAs in premature ovarian failure patients and the potential regulatory function of mir-23a in granulosa cell apoptosis. Reproduction. 2012;144:235–44.
79. Kuang H, Han D, Xie J, Yan Y, Li J, Ge P. Profiling of differentially expressed microRNAs in premature ovarian failure in an animal model. Gynecol Endocrinol. 2014;30:57–61.
80. Rah H, Jeon YJ, Lee BE, Kim JO, Shim SH, Lee WS, et al. Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean women. Menopause. 2013;20:1067–73.
81. Kang H, Lee SK, Kim MH, Song J, Bae SJ, Kim NK, et al. Parathyroid hormone-responsive B1 gene is associated with premature ovarian failure. Hum Reprod. 2008;23:1457–65.
82. Kang H, Lee SK, Cho SW, Lee SH, Kwack K. Branched chain alpha-keto acid dehydrogenase, E1-beta subunit gene is associated with premature ovarian failure. Fertil Steril. 2008;89:728–31.
83. Kang H, Lee SK, Kim MH, Choi H, Lee SH, Kwack K. Acyl-CoA synthetase long-chain family member 6 is associated with premature ovarian failure. Fertil Steril. 2009;91:1339–43.
84. Qin Y, Sun M, You L, Wei D, Sun J, Liang X, et al. ESR1, HK3 and BRSK1 gene variants are associated with both age at natural menopause and premature ovarian failure. Orphanet J Rare Dis. 2012;7:5. 1172-7-5.
85. Knauff EA, Franke L, van Es MA, van den Berg LH, van der Schouw YT, Laven JS, et al. Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod. 2009;24:2372–8.
86. Pyun JA, Cha DH, Kwack K. LAMC1 gene is associated with premature ovarian failure. Maturitas. 2012;71:402–6.
87. Pyun JA, Kang H, Lee SK, Kim MH, Kwack K. Association between polymorphisms in the protein L-isoaspartate (D-aspartate) O-methyltransferase gene and premature ovarian failure. Fertil Steril. 2009;91:1362–5.
88. Aboura A, Dupas C, Tachdjian G, Portnoi MF, Bourcigaux N, Dewailly D, et al. Array comparative genomic hybridization profiling analysis reveals deoxyribonucleic acid copy number variations associated with premature ovarian failure. J Clin Endocrinol Metab. 2009;94:4540–6.
89. Quilter CR, Karcanias AC, Bagga MR, Duncan S, Murray A, Conway GS, et al. Analysis \of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Hum Reprod. 2010;25:2139–50.
90. Zhen XM, Sun YM, Qiao J, Li R, Wang LN, Liu P. Genome-wide copy number scan in Chinese patients with premature ovarian failure. Beijing Da Xue Xue Bao. 2013;45:841–7.
91. McGuire MM, Bowden W, Engel NJ, Ahn HW, Kovanci E, Rajkovic A. Genomic analysis using high-resolution single-nucleotide polymorphism arrays reveals novel microdeletions associated with premature ovarian failure. Fertil Steril. 2011;95:1595–600.
92. Jin M, Yu Y, Huang H. An update on primary ovarian insufficiency. Sci China Life Sci. 2012;55:677–86.
93. Cobo A, Garcia-Velasco JA, Domingo J, Remohi J, Pellicer A. Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients? Fertil Steril. 2013;99:1485–95.